For ALS Awareness Month this year, advocates want to raise the profile of the neurodegenerative disease in support of care, ...

The 25th anniversary celebration of the Wings Over Wall Street benefit will recognize ALS researchers and advocates.

A brain-computer interface that allowed a man, 45, with ALS to communicate using recordings of his own voice has won a $7,500 ...

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Brad Smith, of Arizona, has become the first person with ALS to receive a brain implant from Neuralink as part of an ongoing clinical trial.

RNS60 was well tolerated when inhaled twice daily at home as part of an expanded access program (EAP) for people with ...

Columnist Juliet Taylor explains how her goals and priorities dramatically shifted while living with her late husband's ALS.

While life with ALS brings continued disease progression, columnist Kristin Neva is encouraged by signs of renewal outdoors.

Columnist Dagmar Munn shares the strategy that helps her get unstuck when she's not feeling motivated. Time is precious with ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...